Allianz Asset Management Gmb H Sutro Biopharma, Inc. Transaction History

Allianz Asset Management Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.41 - $8.95 $116,400 - $305,508	-34,135 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$7.78 - $15.31 $135,185 - $266,026	-17,376 Reduced 33.73%	34,135 $280,000
Q4 2021 Feb 11, 2022	SELL	$14.25 - $23.53 $384,180 - $634,368	-26,960 Reduced 34.36%	51,511 $768,000
Q3 2021 Nov 10, 2021	BUY	$16.88 - $22.38 $640,697 - $849,455	37,956 Added 93.68%	78,471 $1.48 Million
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $730,485 - $965,067	40,515 New	40,515 $753,000

140

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $101M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.